Tagged with M

USA Speaking exclusively to PharmaBoardroom at the 2017 BIO Convention in San Diego, former FDA Commissioner Andrew von Eschenbach lifts the lid on the ‘FDA Beyond Our Borders’ project that he initiated. Dr. von Eschenbach, you were the FDA Commissioner for three years, from 2006 to 2009. What do you see…

Indonesia Darodjatun Sanusi, Executive Director of GP Farmasi (National Association of Local Companies in Indonesia), explains the opportunities and challenges that his members are facing as well as the future directions that the industry should take to further enhance its capabilities and continue its growth. As Executive Director of GP Farmasi,…

Hong Kong Shawn, as I understand, SinoMab today is a clinical stage biopharma company focusing on the development of therapeutic monoclonal antibodies (mAbs) – hence the name. Can you tell us a little about the genesis of the company? Having previously studied and worked in the UK and US, I was asked…

Hong Kong Andy Barnett, general manager (Hong Kong and Macau) for Roche, discusses the highlights of his past two years managing a local affiliate instead of heading a global business line, the key factors behind Roche’s top-5 positioning in the local market, and the huge potential for innovation in aspects like digital…

Mexico According to a recent World Health Organization study, countries must allocate at least six percent of their GDP to research and development to be considered to have a healthy investment in this area. As Mexico currently only invests 1.8 percent of its GDP into R&D, there is clearly still a…

Indonesia Rufi Susanto, President (Core Market) and Senior Managing Director IDS Medical Systems (idsMED), highlights the company’s commitment to Indonesia and believes that idsMED’s employees, in combination with continuous investment in their education, are key to making the company succeed. Mr. Susanto, you hold two management roles within idsMED, being the…

Hong Kong Lawrence Wong, general manager of Ferring Pharmaceuticals in Hong Kong, discusses the important role of the Hong Kong affiliate in support of regional operations, the value of the Hong Kong market given that Ferring offers most of its global portfolio here, and how the company philosophy ‘People come first at…

Indonesia Steven Lee, country lead at Siemens Healthineers Indonesia, expands on the strategic change that the company is undergoing in order to fully capture the potential of the Indonesian public and private market. In 2015, Siemens made its healthcare unit an independent organization and just a year ago changed its name…

Algeria A high-level civil servant at the ministry for labour explains in depth the social welfare system in Algeria and specifically how pharmaceutical products are registered and the mechanism for state reimbursement of medicines. Can you please start by introducing the social security system in Algeria, highlighting those features that make…

Ukraine Andy Hunder, president, and Maxim Proskurov, policy officer for healthcare issues, at the American Chamber of Commerce (AmCham Ukraine), provide insights into the Chamber’s main actions and strategic priorities as well as an analysis of the ever-changing business ecosystem of Ukraine, more specifically healthcare, and the role of the AmCham…

Indonesia Honesti Basyir, president director at Kimia Farma, explains the transition towards digitalization in the healthcare industry and his plans to take Kimia Farma from the top six to the top three in the Indonesian pharmaceutical industry by 2019. Mr. Honesti, you were appointed president director of Kimia Farma in April…

Indonesia Jonathan Sudharta, member of the the Board of Directors at Mensa Group, shares insights on the vertical integration strategy of Mensa to offer an end-to-end solution as well as shows how the new investment in Halodoc – a disruptive healthcare mobile application – will help the group to be closer…